Related by context. All words. (Click for frequent words.) 69 Joel Sendek 66 Jon LeCroy 66 analyst Jim Reddoch 65 Annabel Samimy 64 analyst Geoffrey Meacham 63 analyst Jim Birchenough 63 Akhtar Samad 63 Chris Shibutani 63 Gbola Amusa 63 Bret Holley 62 Michael Krensavage 62 Geoff Meacham 62 analyst Jonathan Aschoff 62 Suntrust Robinson Humphrey 62 Jason Kantor 62 Jim Reddoch 62 Joseph Pantginis 62 Geoff Porges 62 Steven Harr 62 Eric Ende 61 analyst Joanne Wuensch 61 George Grofik 61 analyst Amit Hazan 60 analyst Glenn Novarro 60 Geoffrey Porges 60 Mike Krensavage 60 David Amsellem 60 Phil Skolnick 59 Roopesh Patel 59 Bruce Cranna 59 analyst Cory Kasimov 59 Jim Birchenough 59 Dr. Jim Birchenough 59 analyst Jami Rubin 59 Eric Coldwell 59 Mark Schoenebaum 59 Phil Nalbone 59 Geoffrey Meacham 58 Mark Monane 58 Ken Cacciatore 58 Jami Rubin 58 Andreas Theisen 58 Edward Tenthoff 58 analyst Randall Stanicky 58 Jeffrey Holford 58 analyst Ken Trbovich 58 analyst Robert Cihra 58 Jason Kolbert 58 Bruce Nudell 58 Jason Gurda 58 Ian Somaiya 58 analyst Yaron Werber 58 Liana Moussatos 58 Jerry Doctrow 58 Piper Jaffray PJC 58 Trevor Polischuk 58 Olav Zilian 58 Funtleyder 58 analyst Mark Schoenebaum 57 Yaron Werber 57 analyst Bruce Nudell 57 Vishal Shreedhar 57 Joshua Schimmer 57 Joanne Wuensch 57 Dr. Joshua Schimmer 57 Glenn Novarro 57 Seamus Fernandez 56 Karl Heinz Scheunemann 56 Liisa Bayko 56 Sam Fazeli 56 Larry Biegelsen 56 Ambrish Srivastava 56 Molowa 56 Jon Lecroy 56 Claude Camire 56 Carl Seiden 56 Mahesh Sanganeria 55 JoAnne Feeney 55 Tad Piper 55 analyst Liana Moussatos 55 Rajesh Ghai 55 analyst Rommel Dionisio 55 Edwin Hemwall 55 analyst Geoffrey Porges 55 Alexandra Hauber 55 Navid Malik 55 analyst Maged Shenouda 55 Ronny Gal 55 Ehud Gelblum 54 Scott Mushkin 54 Dr. LaMattina 54 Mark Bacurin 54 Betsy Van Hees 54 Cory Kasimov 54 Dr. Yaron Werber 54 Gary Nachman 54 Lawrence Biegelsen 54 Daniel Berenbaum 54 Dhulsini de Zoysa 54 Scott Geels 54 Quynh Pham 54 Kemp Dolliver 54 J. Steven Smigie 54 analyst Dara Mohsenian 54 Kevin Scotcher 54 Sara Michelmore 54 Kin Ho 54 Michael Vinciquerra 54 Kenneth Muth 54 Damien Conover 54 Dave Shove 54 Sanjiv Wadhwani 54 Benjamin Reitzes economist 54 Chris Brendler 54 Atsushi Seki 53 Ulrich Huwald 53 analyst Robert Drbul 53 analyst Raj Denhoy 53 analyst Pablo Zuanic 53 analyst Ambrish Srivastava 53 Carla Antunes da Silva 53 analyst Robert Koort 53 Kochnover 53 Karl Heinz Koch 53 Claudia Shank Hueston 53 Rod Bourgeois 53 analyst Amit Daryanani 53 analyst George Grofik 53 Darren Lehrich 53 Scott Snyder XPRESSTRADE 53 reaffirmed Outperform rating 53 Ramon Llamas IDC 53 Ana Gupte 53 analyst Elemer Piros 53 analyst Frank Mitsch 53 Jeffrey Frelick 53 Curtis Shauger 53 Jonathan Aschoff 53 Leerink Swan 53 analyst Seamus Fernandez 53 John DiFucci 53 Tobias Levkovich 53 Neely Tamminga 53 Randal Konik 53 Brock Vandervliet 53 Seattle Genetics SGEN 53 analyst Randal Konik 52 Reiterates Buy rating 52 Lazard Capital 52 Ahmar Zaman 52 analyst Gbola Amusa 52 Ian de Verteuil 52 WBB Securities LLC 52 analyst Ross Muken 52 Marc Cluzel 52 Rating Maintained 52 analyst Tore Svanberg 52 analyst Tony Wible 52 Brett Hoselton 52 Jason Napodano 52 analyst Kurt Hallead 52 Ricky Goldwasser 52 Bob Drbul 52 RBC Capital NYSE RY 52 Alain Karaoglan 52 B. Nemeroff 52 analyst Gus Papageorgiou 52 analyst Mark Monane 52 PTK ZK 52 analyst Connie Maneaty 52 analyst Shebly Seyrafi 52 analyst Charles Grom 52 Paul Adornato 52 Vertex hepatitis C 52 ThinkEquity LLC 52 Adrienne Tennant 52 FBR Capital NASDAQ FBCM 52 BWS Financial 52 Ronald Tadross 52 Charles Grom 52 analyst Larry Biegelsen 52 Amylin Eli Lilly 52 Tao Levy 52 Satya Chillara 52 Moussatos 52 Michael Turits 52 Raj Denhoy 51 IG HCR ;) CO 51 Lululemon NASDAQ LULU 51 analyst Stacey Widlitz 51 Carl Christensen XPRESSTRADE 51 Curagen 51 Douglas Harned 51 Lauren Cooks Levitan 51 Thomas R. Wadewitz 51 analyst Ajit Pai 51 Matt Miksic 51 analyst Dan Wantrobski 51 Merck boceprevir 51 analyst Randy Ollenberger 51 Robert Breza 51 analyst Ananda Baruah 51 Andrew Speller 51 Joshua Shanker 51 Michael Bruynesteyn 51 Robert Campagnino 51 Randy Ollenberger 51 Steven Alexopoulos 51 Barton Crockett 51 analyst Tim Savageaux 51 TSRX 51 Sterling Auty 51 Mark Swartzberg 51 NASDAQ OSIP announced 51 Suntrust Robinson 51 Matt DiFrisco 51 Andrew Kligerman 51 Aaron Reames 51 CE Unterberg 51 William Tanona 51 analyst Michael Bruynesteyn 51 Millennium Velcade 51 midstage clinical testing 51 analyst Jacques Rousseau 51 Richard Kwas 51 inhibit KSP 51 Sireen Hajj 51 Tony Clapsis 51 Sanjay Vidyarthi 51 Vijay Rakesh 51 Patrick Walravens 51 Derrick Dagnan 51 John Calcagnini 51 Scot Ciccarelli 51 Leerink 51 analyst Emme Kozloff 51 Matthew DiFrisco 51 David Begleiter 51 Thoratec Presentation 51 Kalpesh Kapadia 51 Resumes Coverage 51 Hamed Khorsand 51 Craig Siegenthaler 51 analyst Sapna Srivastava 51 Pantginis 51 Monane 51 Gary Giblen 51 Ari Charney Portfolio 51 Ken Zerbe 51 Stacy Rasgon 50 Anurag Rana 50 analyst Victor Lazarovici 50 Manoj Garg 50 analyst Ghansham Panjabi 50 April Scee 50 Katharine Wynne 50 Avastin Herceptin 50 Glenn Reicin 50 Cannacord Genuity 50 Ziopharm 50 Barclays Maintains 50 James Manuso 50 Jeff Wlodarczak 50 Angelo Airaghi Guest 50 Philip Dorgan 50 David Molowa 50 RBC Capital Mkts Reiterate 50 Gerrick Johnson 50 Ken Trbovich 50 James Janesky 50 ABN AMRO Incorporated 50 Idenix Pharmaceuticals 50 Nasdaq AVNR 50 analyst Junaid Husain 50 Keay Nakae 50 Chris Umiastowski 50 ONXX 50 Analysts Initiate Coverage 50 analyst Sterling Auty 50 Paul Mansky 50 Krensavage Asset Management 50 Donald Fandetti 50 Lawrence Keusch 50 analyst Glenn Schorr 50 Brion Tanous 50 analyst Tim Klasell 50 Constance Maneaty 50 Holger Blum 50 analyst Ehud Gelblum 50 analyst Bruce Cranna 50 Rob Cihra 50 Manuel J. Recarey 50 Dominic Valder 50 Jon Arfstrom 50 Cormac Leech 50 midstage clinical 50 Kenneth Zaslow 50 Mark Astrachan 50 Tanona 50 Leerink Swann 50 NASDAQ ARIA 50 Benjamin Mogil 50 Adam Klauber 50 Schoenebaum 50 Nathan Schneiderman 50 analyst Mitch Kummetz 50 analyst Alexandra Hauber 50 spokeswoman Mariann Caprino 50 analyst Mark Swartzberg 50 Valeant Pharmaceuticals NYSE VRX 50 Mikako Kitagawa Gartner 50 Drew Matus economist 50 Uta Werner 50 Jon Gencher director 50 Jeff Omohundro 50 Brigantine Advisors analyst 50 Mike Trippitt 50 analyst Colby Synesael 50 Medivation Inc 50 Robert Kavcic Economist 50 Analyst Ben Reitzes 50 analyst Edward Yruma 50 FBR Capital Maintains 50 Tristan Gerra 50 Vertex telaprevir 50 analyst Anna Torma 50 ANALYST TAKE Stifel Nicolaus 50 analyst Vivek Arya 50 analyst Bijan Moazami 50 RW Baird analyst 50 Synta Pharmaceuticals 50 Helene Wolk 50 analyst Shotaro Noguchi 50 Sara Senatore 50 Janney Montgomery 50 Vertex VRTX 50 Jean Pierre Lehner 50 Ron Bentsur 50 Joseph Amaturo 50 Analyst Toni Sacconaghi 50 analyst Mark Lipacis 50 Nicholas Landekic 50 analyst Andrey Glukhov 50 Assumes Coverage 50 Joshua Raskin 50 Jay Gelb 50 Matthew Heimermann 50 Gilead Sciences nasdaq GILD 50 analyst Jeff Fidacaro 50 analyst Himanshu Patel 50 analyst Lawrence Keusch 50 Benjamin Schachter 50 Rachael Rothman 50 Simos Simeonidis 50 analyst Gurinder Kalra 49 analyst Uche Orji 49 Mace Rothenberg 49 Stanicky 49 analyst Bruce Harting 49 Christopher Mutascio 49 Randall Stanicky 49 Richard Fetyko 49 Navdeep Jaikaria 49 Natixis Bleichroeder analyst 49 Kevin Ellich 49 ANALYST TAKE Jefferies 49 Reiterates Hold 49 Maher Yaghi 49 JMP Securities downgrade 49 BernsteinResearch 49 Paul Cuddon 49 analyst Anthony Chukumba 49 Edgar Roesch 49 Steven Halper 49 Barry D. Quart 49 analyst Mario Mendonca 49 Edward Najarian 49 Nasdaq IDIX 49 analyst Michael Exstein 49 analyst Charles Boorady 49 Barrie Cornes analyst 49 Analyst Craig Moffett 49 analyst Hari Sambasivam 49 Charles Minervino 49 Jeremy Sussman 49 Paul Lejuez 49 Oppenheimer NYSE OPY 49 Todd Raker 49 Punk Ziegel 49 analyst Alan Bezoza 49 Genentech Herceptin 49 Michael Taiano 49 Kuni Chen 49 Celgene Revlimid 49 Stephen Volkmann 49 Sam Buttrick 49 analyst Jefferson Harralson 49 Georg Marti 49 analyst Mahesh Sanganeria 49 analyst Phillip Nalbone 49 Nicholas Aberle 49 Kenji Masuzoe 49 Feltl & 49 Mumbai Angel Broking 49 Harald Liberge Dondoux 49 John Heinbockel 49 Ken Hoexter 49 WR Hambrecht reiterate 49 Charles DiBona 49 FBR Capital Upgrades 49 analyst Randy Binner 49 analyst Maynard Um 49 Silversteyn 49 A. Sasa Zorovic 49 analyst Joseph Altobello 49 Pat Walravens 49 Geoff Ruddell 49 Mario Mendonca 49 Robyn Karnauskas 49 Eric Beder 49 Marla Backer 49 Glen Yeung 49 Oncogenex 49 Krensavage 49 Recentin 49 Jon Gencher 49 Ann Duignan 49 Analyst Rebecca Arbogast 49 Ralph Giacobbe 49 analyst Lori Appelbaum 49 CE Unterberg Towbin 49 Wedbush Maintains 49 Tellabs Presentation 49 William Plovanic 49 analyst Kemp Dolliver 49 Mumbai IIFL 49 Andy Kaplowitz 49 NASDAQ ACOR 49 analyst Irene Nattel 49 Paul Laikind 49 Robert Spanheimer 49 Georg Kanders 49 Affymax AFFY 49 Brian Piccioni 49 Matthew Borsch 49 analyst Jeffrey Zekauskas 49 Timothy Conder 49 analyst Brad Hintz 49 Leonard Teitelbaum 48 Elan Tysabri 48 Inmet Mining Presentation 48 Fabrizio Croce 48 Mark Kalinowski 48 Ross Muken 48 analyst Constance Maneaty 48 Zocor Zetia 48 Meredith Adler 48 Xenoport Inc. 48 analyst Ajay Jain 48 Joe Osha 48 Justin Yagerman 48 Analyst Cai von 48 Bristol Myers NYSE BMY 48 analyst Kirk Materne 48 Chris Ceraso 48 Sena Lund 48 Alexander Groschke 48 Martin Possienke 48 Hulk Caris & 48 Amevive 48 Pacific Growth Equities 48 Onyx Pharma 48 Johan Eliason 48 analyst Michael Masdea 48 analyst Vijay Jayant 48 analyst Robert Campagnino 48 Ben Mogil 48 Rupak Ghose 48 Anthony Bucalo 48 Justin Hott 48 Ranjit Kapadia 48 Cai von Rumohr 48 ANALYST TAKE JP Morgan 48 Robert Lacoursiere 48 analyst Alexander Peterc 48 John Herrlin 48 Kian Abouhossein 48 Carl A. Pelzel 48 UBS analyst Gbola 48 Jeff Klinefelter 48 #.#.# Amulya Ganguli 48 ThinkEquity 48 Victoria Kusiak 48 Jerry Dellis 48 analyst Christa Quarles 48 Phillip Nalbone 48 Tom Freyman 48 Zadaxin 48 analyst Ashwin Shirvaikar 48 Robert Halver 48 Analyst Cody Acree 48 Roger Perlmutter Amgen 48 Eric Martinuzzi 48 analyst Laura Champine 48 analyst Douglas Sipkin 48 Mark G. Foletta 48 Andrew Obin 48 Jonathan Ruykhaver 48 WBB Securities 48 Kash Rangan 48 Standpoint Research downgraded 48 Andreas Venditti 48 Piper Jaffray Reiterates 48 Christopher Svezia 48 Dylan Cathers 48 analyst Kimberly Greenberger 48 Ananda Baruah 48 Todd Bault 48 Marco Mak 48 Pedro Lichtinger 48 Darren Aftahi 48 analyst Silke Stegemann 48 Ross Seymore 48 Thomas Cholnoky 48 Michael Leuchten 48 Jonathan Dorsheimer 48 Analysts Reiterate 48 Paul Averback 48 Peter Nesvold 48 Nasdaq MOGN 48 Michael Exstein 48 Duane Grubert 48 Rod Lache 48 Todd Duvick 48 Swiss brokerage Helvea 48 Steven Wieczynski 48 Tee Sze Chiah 48 experimental lupus 48 analyst Dorothy Lakner 48 Sumit Dhanda 48 Maintains Neutral 48 Dificid 48 analyst Gregory Melich 48 Douglas Sipkin 48 Brian Gesuale 48 Cantor Fitzgerald reiterates 48 Polymeropoulos 48 Reiterates Buy Rating 48 Georges Gemayel 48 Biomarin Pharm 48 Kristine Koerber 48 Cochran Caronia 48 William F. Tanona 48 Idenix Pharmaceuticals Inc. 48 Savvas Neophytou 48 analyst Budd Bugatch 48 Colin McGranahan 48 Panagiotis Spiliopoulos 48 Les Funtleyder 48 Daniel Junius 48 Dolat Capital Market 48 Jefferies NYSE JEF 48 Gregory Drahuschak 48 Co. nyse LLY 48 Salmedix 48 Marc Kennis 48 Arcalyst 48 analyst Kenneth Zaslow 48 HIV treatments Reyataz 48 analyst Kian Abouhossein 48 analyst Guy Moszkowski 48 Daniel Meron 48 Remi Barbier 48 forecaster IHS Global Insight 48 Mike Trippitt analyst 48 Sumit Malhotra 48 motesanib 48 Tien tsin Huang 48 Michael Linenberg 48 Christopher Horvers 48 Stifel Nicholas 48 David Hochstim 48 www.bmocm.com 48 Safi Bahcall Ph.D. 48 Allen Nogee Principal 48 analyst Vivek Juneja 48 Robert Drbul 48 analyst Robyn Karnauskas 48 analyst Onno Rutten 48 Eli Lilly NYSE LLY 48 Bart Melek 48 ThinkEquity Partners LLC 48 Dirk van Dijk 48 Douglas Anmuth 48 Christopher Hogbin 48 Rick Weinhart 47 Jordan Rohan 47 Dickie Irvin 47 George Scangos 47 Taunya Sell 47 Jochen Rothenbacher 47 Erika Maschmeyer 47 analyst Walter Spracklin 47 NASDAQ SOMX specialty 47 analyst Glenn Reicin 47 Robert Koort 47 Join DailyFX 47 Allos Therapeutics Incorporated 47 Suresh Balaraman 47 analyst Jeffrey Fidacaro 47 Financial XLF Bearish 47 Co. LLY.N 47 economist Kyohei Morita 47 Claudio Aspesi 47 Miller Tabek 47 Sav Neophytou 47 analyst Youssef Squali 47 Tenthoff 47 Suji De Silva 47 Sascha Seegan lead 47 Fulcrum Global Partners 47 analyst Antony Broadbent 47 Sidney Taurel chairman 47 William Pecoriello 47 PFE Short Term 47 Sasa Zorovic 47 Sepracor SEPR 47 analyst Jonathan Schildkraut 47 Jed Dorsheimer 47 Matt Nemer 47 Ittai Kidron 47 NASDAQ GPRO 47 Westcomb Securities 47 analyst Tal Liani 47 Mark A. Sirgo 47 analyst Michael Rehaut 47 Carsten Kunold 47 Merck Finck analyst 47 Isaac Ro 47 Armando Anido 47 NASDAQ SLXP 47 Andrew Vaino 47 analyst Tavis McCourt 47 Rating Reiterated 47 Leerink Swann LLC 47 Reiterates Neutral Rating 47 analyst Safa Rashtchy 47 analyst Inder Singh 47 Inc. Nasdaq GLCH 47 Brean Murray 47 Andrew Barish 47 Cam Doerksen 47 Tom Cholnoky 47 BMRN 47 Lee Klaskow 47 Mabthera 47 Mark Wienkes 47 Nasdaq ANDS announced 47 Elmar Schnee 47 Keybanc 47 analyst Steven Wieczynski 47 United Therapeutics UTHR 47 PiperJaffray analyst 47 Steven Brozak 47 Ton Gietman 47 Amgen Vectibix 47 Gary Hsueh 47 Brigantine Advisors 47 Abbott Niaspan 47 MCM Moneywatch 47 Folotyn 47 UBS analyst Kaumil 47 Adam Barkstrom managing 47 FBR Capital Reiterates 47 Robert Cihra 47 Reiterate Buy rating 47 Guy Moszkowski 47 Singulair asthma 47 analyst Shaul Eyal 47 strategist Makoto Yamashita 47 Dahlman Rose downgraded 47 Nick Selvaratnam 47 Bristol Myers BMY 47 Horst Hueniken 47 Roger Boissonneault 47 Deane Dray 47 Raises PT 47 John LaMattina 47 Michael Shillaker 47 Immunogen 47 Barry Labinger 47 Jon Langenfeld 47 Small Cap Institutional Investor 47 analyst Eric Beder 47 NASDAQ ONXX 47 Rhyee 47 Audio Webcast Presentation 47 Gilead GILD 47 BioCentury NewsMakers 47 analyst Joseph Greff 47 Qlik Technologies Inc 47 Joel Fishbein 47 Bansei Securities 47 analyst Maarten Altena 47 Evolution Beeson Gregory 47 ANALYST TAKE Deutsche 47 Quintin Lai 47 Daniel Brebner 47 Kristine Kubacki 47 Doug Sipkin 47 Gartmore Separate Accounts 47 analyst Tero Weckroth 47 John Reucassel 47 Julian Callow economist 47 analyst Julio Quinteros 47 Competitive Benchmarking Product 47 Jon Balkind 47 Susan Donofrio 47 Patrik Schwendimann 47 Broadpoint Amtech 47 Celgene NASDAQ CELG 47 Ariad Pharmaceuticals 47 George Staphos 47 Bruce Harting 47 Cannacord Adams 47 Sid Parakh analyst 47 NV1FGF 47 Mark Bronzo managing 47 Grofik 47 Cubist Pharma 47 Lauri Brunner 47 Saftlas 47 Carol Levenson 47 Ryland Presentation 47 ImClone Erbitux 47 strategist Peter Boockvar 47 Roche Actemra 47 analyst Bill Pecoriello 47 analyst Sanjay Vidyarthi 47 Orbimed Advisors LLC 47 analyst Jeffrey Klinefelter 47 Drew Matus 47 Nasdaq CELG 47 Forest Labs FRX 47 Scott Krasik 47 Georges Lequime 47 uh ruh 47 analyst Peter Misek 47 economist Ryo Hino 47 Acorda Therapeutics ACOR 47 Stefan Graber 47 Brad Reback 47 Healthcare Tailwinds Conference 47 Reiterates Hold Rating 47 Broadpoint AmTech 47 Orest Wowkodaw 47 Stacey Widlitz analyst 47 ThinkPanmure LLC 47 Michael Masdea 47 Canvaxin 46 Jeremy Batstone 46 Romit Shah 46 Matthew Kather 46 Jennifer Fritzsche 46 Dave Rovelli 46 NASDAQ SCRX specialty 46 Apjit Walia 46 Anthony Gikas 46 Troy Lahr 46 Uche Orji 46 Stephen Tusa 46 Hussein Allidina 46 James Kumpel 46 Wensheng Peng 46 analyst Hunter Keay 46 Freidman Billings Ramsey 46 Steven Burakoff 46 analyst Elizabeth Osur 46 ThinkPanmure 46 Shebly Seyrafi 46 analyst Rod Lache 46 Nigel Dally 46 Broadpoint Capital 46 Shaojing Tong 46 Amgen denosumab 46 Isis Pharma 46 Louis Miscioscia 46 Sackner Bernstein 46 Maintains Overweight 46 Nik Modi 46 Wischik 46 Friedman Billings reiterate 46 Firas Askari 46 Joe Pantginis 46 Steven Winoker 46 Oppenheimer OPY Analysts 46 analyst Katherine Styponias 46 Anadys Pharmaceuticals 46 Inc. NASDAQ EVVV 46 Consumer Discretionary XLY Bearish 46 analyst Richard Fetyko 46 Ali Dibadj 46 Eric de Graaf 46 Aroop Chatterjee 46 Jesse Pichel 46 Inc. NASDAQ ITMN 46 Hunter Keay 46 economist Helen Kevans 46 Tero Kuittinen 46 Analyst Tristan Gerra 46 Leland Westerfield 46 Analyst Steve Brozak 46 analyst Ingrid Sternby 46 Co LLY.N 46 Sarabjit Kour Nangra 46 W. Ruttenbur 46 Wedbush Upgrades 46 Thomas McCrohan 46 Zuercher Kantonalbank welcomed 46 Calyon Securities USA 46 HC Wainwright 46 Bernd Seizinger 46 Piper Jaffray Upgrades 46 analyst Stephen Tusa 46 analyst Dinesh Moorjani 46 George Toriola 46 Gerard Klauer Mattison 46 Michael Jalonen 46 Michael Rehaut 46 Jan Wald 46 Christopher LaFemina 46 ThinkEquity Partners 46 Scott Devitt 46 RBC Capital RY 46 Analyst Sid Parakh 46 Auxilium Pharma 46 Darren Winder 46 Avanir 46 Timna Tanners 46 Chua Hak Bin 46 Antony Broadbent 46 Nasdaq SLXP 46 Ajit Pai 46 Berg BioMarin Pharmaceutical 46 Feltl 46 Narachi 46 drug anacetrapib 46 analyst Edward Sterck 46 analyst Peter Lisnic 46 Gregg Moskowitz 46 Piper Jaffray downgraded 46 spokeswoman Christine Fanelle 46 Mark Edelstone 46 Yvan Bourdeau 46 Avanir Pharmaceuticals 46 Co reaffirms FY# 46 JMP Securities reiterate 46 P. Klinefelter 46 NASDAQ ENDP 46 analyst Louis Miscioscia 46 Shari Schwartzman Eberts 46 Bugg Ph.D. 46 analyst Brent Thill 46 analyst Alex Gauna 46 MER.N 46 Arvind Bhatia 46 economist Tushar Poddar 46 analyst Matthew DiFrisco 46 Steve Massocca 46 Farooq Hanif 46 Gilad Alper 46 RGE Monitor.com contends 46 analyst Dan Wewer 46 SunTrust Robinson 46 Rich Repetto 46 Edwin Groshans 46 Al Kaschalk 46 Biogen multiple sclerosis 46 Philip Cusick 46 Vitaxin 46 Goh Mou Lih 46 James McIlree 46 MRK.N 46 analyst Nigel Dally 46 Nasdaq ISTA 46 Sherri Scribner 46 Tore Svanberg 46 Equinet 46 Shelly Lombard senior 46 Dana Telsey 46 Batlivala & 46 Matthew Emmens 46 Christian Itin 46 analyst Simos Simeonidis 46 Gordon Howald 46 Omer Esiner chief 46 J.P. Morgan Healthcare 46 Broadpoint.AmTech analyst 46 Industrial XLI Bearish 46 Pablo Zuanic 46 FXSolutions 46 JMP Securities LLC 46 Kazaka Securities 46 Analyst Gene Munster 46 analyst Joshua Shanker 46 Canaccord Genuity 46 analyst Albert Savastano 46 Stephen Dashevsky 46 Li Maoyu 46 Andrew Garthwaite 46 Rudy Narvas senior 46 Dr. Emilio Emini 46 SG Cowen Securities 46 BGB Securities 46 Barrie Cornes 46 Emme Kozloff 46 GlaxoSmithKline PLC GSK.LN 46 Elsa Lignos 46 Nicholas Tenev 46 Jessica Reif Cohen 46 Adam Barkstrom 46 Thomas V. Cholnoky 46 Philip Isherwood 46 analyst Sumit Dhanda 46 Landesbank Rheinland Pfalz 46 Drew Brosseau 46 analyst Walter Piecyk 46 Helvea AG 46 Maintains Buy 46 Endo Pharmaceuticals NASDAQ ENDP 46 analyst Brad Reback 46 Willard Dere MD 46 Christophe Menard 46 Tavis McCourt 46 Marco Strittmatter 46 S. Gajrawala 46 John Lechleiter Lilly 46 Christine Farkas 46 Velcade bortezomib 46 Joseph Osha 46 Reicin 46 analyst Mark Edelstone 46 Ken Fujioka 46 Michael Paisan 46 analyst Victor Bareno 46 Brean Murray reiterate 46 anticholesterol 46 Abhijit Chakrabortti 46 Richard Treagus 46 analyst Hussein Allidina 46 Co. analyst Shebly 46 Pulte Homes Presentation 46 analyst Amit Bhalla 46 Inc. NASDAQ ENDP 46 Andrew Parmentier 46 Tubby Goodwin 46 analyst Sasa Zorovic 46 Nasdaq MERR 46 Viktor Dammann 46 NASDAQ INFI 46 economist Masaaki Kanno 46 Steven Wieting 46 Joseph Foresi 46 Kevin Sharer Amgen 46 Wells Fargo Initiates Coverage 46 analyst Kristine Koerber 46 analyst Peter Rhamey 46 Liu Dongliang 46 Two Upcoming Investor 45 JGB strategist 45 Roland Haefeli 45 Jesse Tortora 45 Katherine Styponias 45 JMP Securities JMP 45 Ed Yruma 45 Simulcast Presentation 45 SGP.N Quote Profile Research 45 S. Drbul 45 exenatide LAR 45 Sven Borho partner 45 Alexia Quadrani 45 Allan Mishan 45 Edward Yruma 45 Semiannual Micro Cap 45 Rommel Dionisio 45 John Kartsonas 45 analyst Sanjay Sakhrani 45 Philipp Haessler 45 economist Benjamin Reitzes 45 Laboratories Rahway NJ 45 Nuedexta 45 EXPECTATIONS Analysts polled 45 Kemal Malik 45 Zocor Merck 45 analyst Chris Woronka 45 analyst Gregory Badishkanian 45 ThinkEquity upgraded 45 maker Barr Pharmaceuticals 45 Novartis Gilenia